NovaBay Pharmaceuticals, Inc. (NYSE: NBY)
Julie & Holleman LLP, a preeminent shareholder rights law firm, announces that it is investigating matters involving NovaBay Pharmaceuticals, Inc. (NYSE: NBY). The firm’s investigation seeks to determine with NovaBay’s directors breached their fiduciary duties in connection with recent corporate actions.
For a free, no-risk consultation or more information, please, please fill out the form below, or contact partner Scott Holleman at (917) 325-3798 or scott@julieholleman.com. There is no cost or obligation to you.
Thank you for your response. ✨
Thank you for your submission! A member of our team will get back to you within 1-2 business days.